MedTrace Logo

ABRE Clinical Study of the Abre Venous Self-expanding Stent System

NCT03038438 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 260

Last updated 2022-11-08

Study results available
· View outcomes & findings →

Summary

Evaluate the safety and effectiveness of the Abre venous self-expanding stent system for treatment of symptomatic iliofemoral venous outflow obstruction in patients with venous occlusive disease.

Conditions

  • Iliofemoral Venous Obstruction

Interventions

DEVICE

Abre venous self-expanding stent system

venous stent

Sponsors & Collaborators

  • Medtronic Endovascular

    lead INDUSTRY

Principal Investigators

  • Erin Murphy, MD · Carolinas Health Care System

  • Stephen Black, MD · Guy's and St Thomas' NHS Foundation Trust

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-13
Primary Completion
2020-01-14
Completion
2022-01-28
FDA Device
Yes

Countries

  • United States
  • France
  • Germany
  • Ireland
  • Italy
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03038438 on ClinicalTrials.gov